Medroxyprogesterone-induced endocrine alterations after menopause

Menopause

Volumn 9, Issue 4, 2002, Pages 288-292

  Saaresranta, Tarja ^a   Irjala, Kerttu ^a   Polo Kantola, Päivi ^a   Polo, Olli ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aftereffect; Medroxyprogesterone; Progestogen; Woman

Indexed keywords

FOLLITROPIN; GESTAGEN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; DRUG EFFECT; DRUG INDICATION; ENDOCRINE SYSTEM; FEMALE; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; HYPOXEMIA; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 0036308876     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200207000-00010     Document Type: Article

References (23)

1. The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-I in women with advanced breast cancer
2. Effect of short term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women
3. Igf-I and ventilation after short-term progestin in postmenopausal women with chronic respiratory insufficiency
4. Effects of medroxyprogesterone acetate in women with polycystic ovary syndrome
5. Serum testosterone, androstenedione and luteinizing hormone levels after short-term medroxyprogesterone acetate treatment in women with polycystic ovarian disease
6. Prolonged endocrine responses to medroxyprogesterone in postmenopausal women with respiratory insufficiency
7. Medroxyprogesterone in postmenopausal females with partial upper airway obstruction during sleep
8. Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma
9. Disposition of medroxyprogesterone acetate and drug metabolism activity
10. Source of estrogen production in postmenopausal women
11. The hormonal activity of the postmenopausal ovary
12. Role of extraglandular estrogen in human endocrinology
13. Hormonal therapy in cancer of the breast, XXIV: Effect of corticosterone or medroxyprogesterone acetate on clinical course and hormonal excretion
14. Short-term progestogen treatment of endometrial carcinoma: Histological, histochemical and hormonal studies
15. The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients
16. Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer, I: General findings
17. Effects produced in rats by the administration of 6-alfa-methyl-17-alfa-hydroxyprogesterone acetate from birth to maturity
18. Modulation of immunoreactive somatomedin-C levels by sex steroids
19. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages
20. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats
21. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism)
22. Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring
23. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells